Revenio Group Oyj
OTC:REVXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revenio Group Oyj
OTC:REVXF
|
FI |
|
Class 1 Nickel and Technologies Ltd
F:77C
|
CA |
|
First Phosphate Corp
F:KD0
|
CA |
|
S
|
Shanghai Electric Group Co Ltd
SWB:USR
|
CN |
|
D
|
Dutch Lady Milk Industries Bhd
KLSE:DLADY
|
MY |
|
J
|
Japan Airlines Co Ltd
F:JAL
|
JP |
|
C
|
China Railway Hi-tech Industry Corp Ltd
SSE:600528
|
CN |
Intrinsic Value
Is REVXF undervalued or overvalued?
See the intrinsic value estimate for Revenio Group Oyj and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
REVXF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with REVXF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Revenio Group Oyj Does
Revenio Group Oyj is a medical technology company best known for devices and software used to screen and monitor eye disease, especially glaucoma and other conditions that can damage vision. It also makes tools for bone health assessment. The company sells mainly to eye clinics, hospitals, screening programs, and other healthcare providers that need reliable diagnostic equipment.
- Headquarters
- Finland FI
- Employees
- 246
- IPO date
- Jan 1, 2003
Latest Earnings Call
- EPS
- €0.05
- Expected
- €0.11
- Surprise
- −54.5%
- Stock, day of the call
- 0.0%
Revenue & Expenses Breakdown
Revenio Group Oyj
Earnings Waterfall
Revenio Group Oyj
The intrinsic value for Revenio Group Oyj (REVXF) under the Base Case is hidden USD.
Compared with the current market price of 13.5442 USD, the stock appears hidden.